Optimising clinical trial design to manage placebo response in randomised controlled trials of irritable bowel syndrome
- PMID: 33765446
- DOI: 10.1016/S2468-1253(21)00056-X
Optimising clinical trial design to manage placebo response in randomised controlled trials of irritable bowel syndrome
Comment on
-
The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2021 Jun;6(6):459-473. doi: 10.1016/S2468-1253(21)00023-6. Epub 2021 Mar 23. Lancet Gastroenterol Hepatol. 2021. PMID: 33765447
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
